Valuation: Medtronic plc

Capitalization 108B 102B 94.4B 84.18B 152B 9,136B 167B 1,174B 433B 3,749B 404B 395B 16,260B P/E ratio 2025 *
20.3x
P/E ratio 2026 * 18.5x
Enterprise value 131B 124B 115B 102B 185B 11,096B 202B 1,425B 526B 4,553B 491B 480B 19,749B EV / Sales 2025 *
3.9x
EV / Sales 2026 * 3.7x
Free-Float
99.72%
Yield 2025 *
3.4%
Yield 2026 * 3.56%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.06%
1 week-2.98%
Current month-2.98%
1 month-4.29%
3 months-7.35%
6 months-0.13%
Current year+1.92%
More quotes
1 week
83.57
Extreme 83.57
86.12
1 month
83.55
Extreme 83.55
88.82
Current year
75.96
Extreme 75.96
92.68
1 year
75.96
Extreme 75.96
92.68
3 years
68.84
Extreme 68.84
114.31
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Director TitleAgeSince
Chief Executive Officer 54 26/04/2020
Chief Tech/Sci/R&D Officer 63 31/05/2023
Chief Operating Officer 64 31/03/2021
Manager TitleAgeSince
Director/Board Member 64 25/01/2015
Director/Board Member 62 31/12/2012
Director/Board Member 68 31/12/2014
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.06%-2.98%+5.81%-25.57%108B
-0.61%-1.64%+9.94%-13.30%199B
+1.36%+0.09%-4.00%-9.02%64.48B
+0.59%+1.75%+20.48%+14.01%46.68B
-1.19%-3.75%+19.21%+97.64%46.49B
-1.79%-2.36%+27.25%+29.37%30.2B
+0.89%-1.13%-32.97%-44.01%30.63B
-0.10%-0.15%-5.87%-24.94%23.33B
+1.33%-0.93%-6.68%-12.73%21.79B
-0.12%-1.48%+7.55%-7.20%21.28B
Average -0.09%-0.90%+4.07%+0.42% 59.18B
Weighted average by Cap. -0.18%-1.54%+6.57%-3.83%
See all sector performances

Financials

2025 *2026 *
Net sales 33.56B 31.72B 29.42B 26.24B 47.39B 2,848B 51.92B 366B 135B 1,168B 126B 123B 5,068B 35.11B 33.18B 30.78B 27.45B 49.58B 2,979B 54.32B 383B 141B 1,222B 132B 129B 5,302B
Net income 5.3B 5.01B 4.65B 4.14B 7.49B 450B 8.2B 57.78B 21.33B 185B 19.9B 19.47B 801B 5.81B 5.49B 5.09B 4.54B 8.2B 493B 8.98B 63.29B 23.36B 202B 21.8B 21.33B 877B
Net Debt 23.1B 21.83B 20.26B 18.06B 32.62B 1,960B 35.74B 252B 92.96B 804B 86.75B 84.85B 3,489B 22.16B 20.95B 19.43B 17.33B 31.3B 1,881B 34.29B 242B 89.19B 772B 83.23B 81.41B 3,347B
More financial data * Estimated data
Logo Medtronic plc
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (26%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.5%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (18%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - cranial and spinal technologies (14.7%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (9%); - diabetes management (7.7%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.4%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ; - other (0.7%). Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Employees
95,000
Calendar
More about the company
Date Price Change Volume
10/12/24 83.61 $ -0.42% 1,538,558
09/12/24 83.96 $ -0.06% 5,015,090
06/12/24 84.01 $ -0.15% 4,310,061
05/12/24 84.14 $ -1.38% 6,967,690
04/12/24 85.32 $ -0.46% 5,352,529

Delayed Quote Nyse, December 09, 2024 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C
surperformance-ratings-light-chart MEDTRONIC-PLCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
83.96USD
Average target price
96.43USD
Spread / Average Target
+14.85%
Consensus

Quarterly revenue - Rate of surprise